CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-06-01 | FRIEDMANN NADAV Chief Operating Officer | Option exercise · Common Stock | −96,790 | $5.12 | $496K | 3,085,074 |
| 2011-06-01 | SCHOENHARD GRANT Chief Scientific Officer | Grant or award · Common Stock | +70,000 | $10.00 | $700K | 887,024 |
| 2011-06-01 | BARBIER REMI Chief Executive Officer/Chairm | Grant or award · Stock Options | +300,000 | $10.00 | $3.0M | 4,237,492 |
| 2011-06-01 | FRIEDMANN NADAV Chief Operating Officer | Grant or award · Stock options | +150,000 | $10.00 | $1.5M | 3,181,864 |
| 2011-06-01 | RODDY PETER S Chief Financial Officer | Grant or award · Stock Options | +70,000 | $10.00 | $700K | 1,106,866 |
| 2011-05-19 | O DONNELL MICHAEL J Director | Grant or award · Non-Qualifying Stock Option | +25,000 | $9.14 | $229K | 320,308 |
| 2011-05-19 | GUSSIN ROBERT Z Director | Grant or award · Non-Qualifying Stock Options | +25,000 | $9.14 | $229K | 477,804 |
| 2011-05-19 | ROBERTSON SANFORD Director | Grant or award · Non-Qualifying Stock Option | +25,000 | $9.14 | $229K | 477,804 |
| 2011-05-19 | SCANNON PATRICK J MD PHD Director | Grant or award · Non-Qualifying Stock Options | +25,000 | $9.14 | $229K | 234,996 |
| 2011-05-19 | GUSSIN ROBERT Z Director | Option exercise · Non-Qualifying Stock Options | +25,000 | $9.14 | $229K | 477,804 |
| 2011-05-19 | O DONNELL MICHAEL J Director | Option exercise · Non-Qualifying Stock Option | +25,000 | $9.14 | $229K | 320,308 |
| 2011-05-13 | O DONNELL MICHAEL J Director | Option exercise | +32,811 | $6.76 | $222K | 38,586 |
| 2011-05-13 | O DONNELL MICHAEL J Director | Shares withheld for taxes | −24,618 | $9.01 | $222K | 13,968 |
| 2011-05-13 | O DONNELL MICHAEL J Director | Option exercise · Non-Qualifying Stock Option | −32,811 | $6.76 | $222K | 295,308 |
| 2011-05-13 | O DONNELL MICHAEL J Director | Option exercise | +32,811 | $6.76 | $222K | 38,586 |
| 2011-05-13 | O DONNELL MICHAEL J Director | Shares withheld for taxes | −24,618 | $9.01 | $222K | 13,968 |
| 2011-05-13 | O DONNELL MICHAEL J Director | Option exercise · Common Stock | −32,811 | $6.76 | $222K | 295,308 |
| 2011-05-04 | RODDY PETER S Chief Financial Officer | Gift | −7,000 | 54,750 | ||
| 2011-05-02 | RODDY PETER S Chief Financial Officer | Other acquisition | +5,228 | $2.87 | $15K | 61,750 |
| 2011-05-02 | FRIEDMANN NADAV Chief Operating Officer | Other acquisition | +4,357 | $2.87 | $13K | 287,022 |
Page 20 of 25 · 498 trades